Despite treatment with statins, many patients with high cholesterol levels will nevertheless increase in cardiovascular disease. Not the most effective cholesterol; however, the immune system plays an essential role in atherosclerosis development. Researchers now offer a unique reason behind this residual cardiovascular threat, associated with chronic activation of the immune system in sufferers with hypercholesterolemia who are treated with statins.
Hypercholesterolemia is a primary threat issue for cardiovascular disease. Statins are the most widely used LDL cholesterol-reducing pills. However, regardless of the remedy with statins, many patients with elevated cholesterol levels will nonetheless develop cardiovascular diseases. Currently, it’s far obvious that no longer the handiest cholesterol; however, the immune system plays a critical role in the development of atherosclerosis, but how cholesterol and the immune system engage is still unraveled. A latest takes a look at from the Netherlands now offers a unique explanation for this residual cardiovascular hazard, related to the continual activation of the immune system in patients with hypercholesterolemia treated with statins.
Siroon Bekkering, Radboud College Scientific Center, Nijmegen, with colleagues from Amsterdam and Rotterdam, investigated the pastime of a part of the immune system in people with and without high cholesterol levels. It seemed that precise immune cells within the blood (‘monocytes’) were greater activated in sufferers with excessive cholesterol levels than in people with ordinary levels of cholesterol; these cells produced extra inflammatory molecules, which might be crucial within the development of cardiovascular disease. Subsequently, the sufferers with excessive LDL cholesterol have been treated with statins to decrease their cholesterol levels, and the same measurements were repeated 3 months later. Importantly, despite cholesterol-lowering, the hyperactivity of the immune cells did not decrease at all. Niels Riksen, professor of inner medicine from the Radboud college medical center and coordinator of the project, states that “we, therefore, determined that those immune cells seem to ‘recall’ the high LDL cholesterol, they as soon as we’re exposed to. The finding that monocytes cannot forget previous exposures has only recently been discovered. It has been termed ‘educated immunity,’ which is the primary examination to illustrate this in patients.” According to Riksen, it might be thrilling to research how long this reminiscence lasts and whether or not the hyperactivity of the monocytes can be decreased by other drug types, such as an anti-inflammatory drug.
Siroon Bekkering, Lotte C.A. Stiekema, Sophie Bernelot Moens, Simone L. Verweij, Boris Novakovic, Koen Prange, Miranda Versloot, Jeanine E. Roeters van Lennep, Henk Stunnenberg, Menno de Winther, Erik S.G. Stroes, Leo A.B. Joosten, Mihai G. Netea, Niels P. Riksen. Treatment with Statins Does Not Revert Trained Immunity in Patients with Familial Hypercholesterolemia. You’ve probably seen those commercials for cholesterol medications, typically statin drugs, which discuss the ways that you might develop high cholesterol in the first place. You know, the ones that show a piece of food that might contribute to high cholesterol and then show a photo of a family member who has an uncanny resemblance to that food. I, for one, would never want to have my photo compared to a deviled egg and find a strange similarity, but the commercial gets its point across in a memorable way. High cholesterol and hyperlipidemia are often connected to two different things: dietary choices and genetics. However, statin drugs are not your only weapon. Acupuncture and Chinese herbal medicine can be used in combination with smart dietary choices to decrease cholesterol levels in the body and delay medication usage or decrease reliance on it.
